Benitec Biopharma Inc.

Menu

  • About Us
    • Overview
    • Board
    • Team
    • Corporate Directory
  • Our Science
    • Gene Silencing
    • Intellectual Property
    • Partnering
  • Our Programs
    • Areas of Research
    • Pipeline
    • Out-Licensed Programs
    • Presentations and Publications
  • For Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Media Coverage
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Annual Reports
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Media Coverage
  • Email Alerts
Feb 24, 2021 8:29am EST

Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study

Dec 07, 2020 2:33pm EST

Benitec Biopharma Announces 2020 Annual Stockholder Meeting

Oct 06, 2020 4:05pm EDT

Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares

Oct 02, 2020 9:05am EDT

Benitec Biopharma Announces Pricing of $10.0 Million Public Offering

Sep 23, 2020 4:54pm EDT

Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results

Sep 01, 2020 8:15am EDT

Benitec Biopharma to present at H.C. Wainwright's 22nd Annual Global Investment Conference

Jul 08, 2020 8:00am EDT

Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study

Apr 15, 2020 8:52am EDT

Benitec Biopharma Announces the Completion of Redomiciliation to the United States

Apr 14, 2020 9:28pm EDT

Benitec Biopharma Appoints Edward Smith to the Board of Directors

Mar 30, 2020 10:09am EDT

Benitec Announces Supreme Court of Queensland Approval for Redomicile

  • 1
  • 2
  • 3
  • 4
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • About Us
    • Overview
    • Board
    • Team
    • Corporate Directory
  • Our Science
    • Gene Silencing
    • Intellectual Property
    • Partnering
  • Our Programs
    • Areas of Research
    • Out-Licensed Programs
    • Pipeline
    • Presentations and Publications
  • For Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance

Address

Benitec Biopharma
3940 Trust Way
Hayward, CA. 94545
United States
P: +61 (0)3 8692-7222

Benitec Biopharma Inc.

By Drawhistory & Hatchet